TRIB
Trinity Biotech plcNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$11.42M
P/E Ratio
—
EPS
$-1.60
Beta
0.79
52W High
$1.97
52W Low
$0.50
50-Day MA
$0.73
200-Day MA
$0.91
Dividend Yield
—
Profit Margin
-75.90%
Forward P/E
—
PEG Ratio
1.30
About Trinity Biotech plc
Trinity Biotech plc acquires, develops, manufactures and markets medical diagnostic products for the clinical laboratory and point of care (POC) segments of the diagnostic market in the United States, Africa, Asia and Europe. The company is headquartered in Bray, Ireland.
Fundamentals
| Revenue (TTM) | $48.57M |
| Gross Profit (TTM) | $17.87M |
| EBITDA | $-14.03M |
| Operating Margin | -3.56% |
| Return on Equity | -1913.00% |
| Return on Assets | -9.46% |
| Revenue/Share (TTM) | $1.97 |
| Book Value | $-2.93 |
| Price-to-Book | 5.11 |
| Price-to-Sales (TTM) | 0.23 |
| EV/Revenue | 2.477 |
| EV/EBITDA | -6.06 |
| Quarterly Earnings Growth (YoY) | -77.30% |
| Quarterly Revenue Growth (YoY) | -5.50% |
| Shares Outstanding | $18.90M |
| Float | $293.05M |
| % Insiders | 17.95% |
| % Institutions | 4.54% |
Historical Volatility
HV 10-Day
69.13%
HV 20-Day
90.51%
HV 30-Day
79.21%
HV 60-Day
83.17%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/9/2026